U.S. flag

An official website of the United States government

NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser) AND Deficiency of steroid 11-beta-monooxygenase

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Oct 30, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000001238.3

Allele description [Variation Report for NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser)]

NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser)

Gene:
CYP11B1:cytochrome P450 family 11 subfamily B member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q24.3
Genomic location:
Preferred name:
NM_000497.4(CYP11B1):c.124C>T (p.Pro42Ser)
HGVS:
  • NC_000008.11:g.142879690G>A
  • NG_007954.1:g.5131C>T
  • NG_055454.1:g.68G>A
  • NM_000497.4:c.124C>TMANE SELECT
  • NM_001026213.1:c.124C>T
  • NP_000488.3:p.Pro42Ser
  • NP_000488.3:p.Pro42Ser
  • NP_001021384.1:p.Pro42Ser
  • NC_000008.10:g.143961106G>A
  • NM_000497.3:c.124C>T
  • P15538:p.Pro42Ser
Protein change:
P42S; PRO42SER
Links:
UniProtKB: P15538#VAR_001260; OMIM: 610613.0009; dbSNP: rs104894069
NCBI 1000 Genomes Browser:
rs104894069
Molecular consequence:
  • NM_000497.4:c.124C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001026213.1:c.124C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Deficiency of steroid 11-beta-monooxygenase (CYP11B1)
Synonyms:
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY; 11-beta-hydroxylase deficiency; Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008729; MedGen: C0268292; OMIM: 202010

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000021388OMIM
no assertion criteria provided
Pathogenic
(Oct 1, 1997)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV004215325Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 30, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency.

Joehrer K, Geley S, Strasser-Wozak EM, Azziz R, Wollmann HA, Schmitt K, Kofler R, White PC.

Hum Mol Genet. 1997 Oct;6(11):1829-34.

PubMed [citation]
PMID:
9302260

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000021388.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a patient with partial steroid 11-beta-hydroxylase deficiency (202010), Joehrer et al. (1997) identified compound heterozygosity for 2 mutations in the CYP11B1 gene: a pro42-to-ser (P42S) substitution and a nonsense mutation (Y423X; 610613.0015). The patient, diagnosed at 5 years of age with an advanced bone age of 12 years, was in the 75th percentile for height and had acne and precocious puberty. The proline at codon 42 is conserved in all CYP11B isozymes and in rather distantly related enzymes such as P450cam (EC 1.14.15.1). A mutation at the corresponding position in CYP21 (P30L; 201910.0004) causes mild 21-hydroxylase deficiency. The protein carrying the P42S mutation retained partial enzyme activity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004215325.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024